Medicines | Representational image | Pexels
Medicines | Representational image | Pexels
Text Size:

New Delhi: The new Modi government is looking to plug loopholes in doctors issuing e-prescriptions as part of its efforts to regulate the online sale of medicines in India.

An e-prescription or e-Rx is one that is sent electronically by a doctor to a patient. It is generally considered error-free and legible, unlike the handwritten prescriptions where chances of errors or modifications are high.

In India, however, e-pharmacy apps allow users to merely upload a snapshot of a prescription as opposed to the electronic version. This practice has raised questions on the authenticity of prescriptions being sent to e-pharmacy outlets through mobile apps.

The issue was discussed at a high-profile meeting on 10 June, chaired by secretaries and joint secretaries from the Ministry of Health, Department of Pharmaceuticals along with the top officials of the Niti Aayog, the Drug Controller General of India and drug commissioners.

“In a takeaway from the meeting, we may define the format of the prescriptions that could be used for placing orders at e-pharmacies,” said a senior official from the Ministry of Health who was a part of the meeting.

“Various stakeholders have found this to be a grey area. The chemist associations, such as the AIOCD, have found various prescriptions to be fake, tampered or modified or repeated prescriptions,” he said.

“It is a serious concern which, if not regulated, could be exploited at e-pharmacies.”

We are deeply grateful to our readers & viewers for their time, trust and subscriptions.

Quality journalism is expensive and needs readers to pay for it. Your support will define our work and ThePrint’s future.

SUBSCRIBE NOW

The AIOCD or the All India Organisation of Chemists and Druggists is the country’s largest chemist body representing over eight lakh pharmacists.


Also read: European regulator finds cancer-causing element in diabetes medicines made in India


The plan

The government is planning to define ‘e-prescription’ under the draft of the e-pharmacy regulations.

Online pharmacies currently do not fall under the ambit of any existing law and are temporarily working on the principles of their brick-and-mortar counterparts. The Central Drugs Standard Control Organisation (CDSCO), the national regulatory body for medicines, is working on finalising the draft rules that were released by the health ministry in September 2018.

“We will understand the present laws in the developed countries and their format of designing online prescriptions,” the official quoted above said. “The final policy could incorporate the definition of e-Rx.”

E-prescriptions have proved beneficial for patient safety across the world. According to the United States health department, e-prescriptions, adopted in 2003 under the Medicare Modernization Act (MMA), have reduced medication errors in the country.

In Europe, the use of electronic prescription is counted among the strategic steps to improve health care. Countries such as Norway, Sweden, Belgium, Italy, England, Scotland and Denmark also use e-prescriptions on a regular basis.

Regulating hazardous medicines

The government is also working on the list of drugs that cannot be sold online. While the government plans to bar narcotic drugs and psychotropic substances, the medical bodies, including the India Medical Association, chemist associations and the Gujarat Pharmacy Council, have asked it to extend the list.

In the meeting, the government has deliberated on barring the other hazardous categories including the Schedule H and Schedule H1 drugs.

“We are considering to regulate the list of drugs that could be sold online,” the official said. “However, it is a critical subject and discussions are going on.”


Also read: Nearly 400 cancer medicine prices slashed by up to 87%


Subscribe to our channels on YouTube & Telegram

News media is in a crisis & only you can fix it

You are reading this because you value good, intelligent and objective journalism. We thank you for your time and your trust.

You also know that the news media is facing an unprecedented crisis. It is likely that you are also hearing of the brutal layoffs and pay-cuts hitting the industry. There are many reasons why the media’s economics is broken. But a big one is that good people are not yet paying enough for good journalism.

We have a newsroom filled with talented young reporters. We also have the country’s most robust editing and fact-checking team, finest news photographers and video professionals. We are building India’s most ambitious and energetic news platform. And we aren’t even three yet.

At ThePrint, we invest in quality journalists. We pay them fairly and on time even in this difficult period. As you may have noticed, we do not flinch from spending whatever it takes to make sure our reporters reach where the story is. Our stellar coronavirus coverage is a good example. You can check some of it here.

This comes with a sizable cost. For us to continue bringing quality journalism, we need readers like you to pay for it. Because the advertising market is broken too.

If you think we deserve your support, do join us in this endeavour to strengthen fair, free, courageous, and questioning journalism, please click on the link below. Your support will define our journalism, and ThePrint’s future. It will take just a few seconds of your time.

Support Our Journalism

3 Comments Share Your Views

3 COMMENTS

  1. I believe we should focus on the regulation of pharmacy stores before we focus on e-Rx. The first thing we should mandate is each pharmacy store has to have an electronic system. Second, we should have centralized software just like developed countries have. Having Rx software will eliminate so many medication errors, drug interactions. Currently, the pharmacist at the drug store doesn’t check the prescription for dose, drug interaction upon receipt. They just dispense the medication. Last, we should focus on e-Rx.

  2. Generic drugs prescription is important. This alone will reduce malpractices with drugs and it will also reduce cost remarkably.

  3. E pris is a dangerous game of collision between pharma companies doctors insurance. Patient will be wiped out if insurance covers are not there. If insurance is made insurance covers will share booty with doc +pharma+ Insurance.

LEAVE A REPLY

Please enter your comment!
Please enter your name here